98%
921
2 minutes
20
Aims: methods provide a resourceful toolbox for new approach methodologies (NAMs). They can revolutionize chemical safety assessment by offering more efficient and human-relevant alternatives to traditional animal testing. In this study, we introduce two Liver Physiological Maps (PMs); comprehensive and machine-readable graphical representations of the intricate mechanisms governing two major liver functions.
Methods: Two PMs were developed through manual literature curation, integrating data from established pathway resources and domain expert knowledge. Cell-type specificity was validated using Human Protein Atlas datasets. An interactive version is available online for exploration. Cross-comparison analysis with existing Adverse Outcome Pathway (AOP) networks was performed to benchmark physiological coverage and identify knowledge gaps.
Results: The LiverLipidPM focuses on liver lipid metabolism, detailing pathways involved in fatty acid synthesis, triglycerides, cholesterol metabolism, and lipid catabolism in hepatocytes. And the LiverBilePM represents bile acid biosynthesis and secretion processes, detailing biosynthesis, transport, and secretion processes between hepatocytes and cholangiocytes. Both maps integrate metabolism with signaling pathways and regulatory networks. The interactive maps enable visualization of molecular pathways, linkage to external ontologies, and overlay of experimental data. Comparative analysis revealed unique mechanisms to each map and overlaps with existing AOP networks. Chemical-target queries identified new potential targets in both PMs, which might represent new molecular initiating events for AOP network extension.
Conclusion: The developed liver PMs serve as valuable resources for hepatology research, with a special focus on hepatotoxicity, supporting the refinement of AOP networks and the development of human-oriented test batteries for chemical toxicity assessment. These maps provide a foundation for creating computational models and mode-of-action ontologies while potentially extending their utility to systems biology and drug discovery applications.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12277266 | PMC |
http://dx.doi.org/10.3389/ftox.2025.1619651 | DOI Listing |
Environ Mol Mutagen
September 2025
Department of Biology, University of Ottawa, Ottawa, Ontario, Canada.
Long-duration spaceflight exposes astronauts to various stressors that can alter human physiology, potentially causing immediate and long-term health effects. These stressors can damage biomolecules, cells, tissues, and organs, leading to adverse outcomes. Developing adverse outcome pathways (AOPs) relevant to radiation exposure can guide research priorities and inform risk assessments of future space exploration activities.
View Article and Find Full Text PDFAge Ageing
August 2025
Department of Social Determinants of Health, Division of Healthier Populations, World Health Organization, Geneva, Switzerland.
The Abuse of Older People - Intervention Accelerator (AOP-IA) project aims to accelerate the development of effective interventions to prevent and reduce AOP aged 60 and older within the framework of the United Nations Decade of Healthy Ageing (2021-2030). The AOP-IA was launched in response to the global need for interventions with proven effectiveness, as few existing approaches have been rigorously evaluated. This paper focuses on the first two phases of the AOP-IA project, which involved conducting a systematic search, screening and evaluation process to identify candidate interventions ready to be rigorously evaluated in future stages of the project, as well as establishing a network of intervention developers.
View Article and Find Full Text PDFEur Heart J Open
September 2025
Department of Cardiology, Centre Hospitalier Universitaire de Besançon, Besançon, France.
Intensive Care Med
September 2025
The University of Queensland, UQ Centre for Clinical Research, Brisbane, Australia.
Background: Early antibiotic therapy for patients with severe infections is essential to improve outcomes. Conversely, use of overly broad antibiotic therapy for susceptible pathogens or unnecessary antibiotics in patients without bacterial infections is associated with adverse life-threatening events and superinfections. Antibiotics-induced changes in the human microbiota alter both immune and metabolic systems.
View Article and Find Full Text PDFEnviron Toxicol Chem
September 2025
National Food Institute, Technical University of Denmark, Kgs. Lyngby, DK-2800Denmark.
This report outlines an adverse outcome pathway network (AOPN) linking reduced androgen signalling during the fetal masculinization programming window to shortened anogenital distance (AGD) at birth. In mammals such as mice, rats, and humans, the AGD is approximately twice as long in males as in females, driven by androgen-dependent differentiation of the male phenotype. Impaired androgen signalling during fetal development can lead to a significantly shorter AGD in male offspring, a sexually dimorphic feature widely used in rodent toxicity studies and human epidemiological research to assess exposure to anti-androgenic substances.
View Article and Find Full Text PDF